Aster Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Aster Capital Management's MDGL Position: Q3 2026 in Review
Aster Capital Management sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2026, closing a stake of 444 shares — an estimated $238K sold.
Aster Capital Management first reported a position in MDGL in Q1 2025 and held it in 4 quarters. The position peaked at $748K in Q1 2025. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Aster Capital Management reported no remaining Madrigal Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Aster Capital Management sold 444 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $238K.
- Aster Capital Management first reported a position in Madrigal Pharmaceuticals in Q1 2025 and held it in 4 quarters.
- Aster Capital Management's Madrigal Pharmaceuticals position peaked at $748K in Q1 2025.
- 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.